Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Gains from Investment Securities (2021 - 2025)

Biote has reported Gains from Investment Securities over the past 5 years, most recently at $266849.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $266849.0 for Q4 2025, down 97.41% from a year ago — trailing twelve months through Dec 2025 was $266849.0 (down 97.41% YoY), and the annual figure for FY2025 was $266849.0, down 97.41%.
  • Gains from Investment Securities for Q4 2025 was $266849.0 at Biote, roughly flat from $266849.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for BTMD hit a ceiling of $11.8 million in Q2 2023 and a floor of -$6.0 million in Q2 2021.
  • Median Gains from Investment Securities over the past 5 years was $266849.0 (2025), compared with a mean of $2.4 million.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 956.0% in 2022 and later surged 7476.44% in 2023.
  • Biote's Gains from Investment Securities stood at $9.8 million in 2021, then plummeted by 105.86% to -$575000.0 in 2022, then skyrocketed by 748.28% to $3.7 million in 2023, then skyrocketed by 176.6% to $10.3 million in 2024, then plummeted by 97.41% to $266849.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $266849.0 (Q4 2025), $266849.0 (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.